» Articles » PMID: 21206091

Dysregulation of the ALS-associated Gene TDP-43 Leads to Neuronal Death and Degeneration in Mice

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2011 Jan 6
PMID 21206091
Citations 250
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characterized by cytoplasmic protein aggregates in the brain and spinal cord that include TAR-DNA binding protein 43 (TDP-43). TDP-43 is normally localized in the nucleus with roles in the regulation of gene expression, and pathological cytoplasmic aggregates are associated with depletion of nuclear protein. Here, we generated transgenic mice expressing human TDP-43 with a defective nuclear localization signal in the forebrain (hTDP-43-ΔNLS), and compared them with mice expressing WT hTDP-43 (hTDP-43-WT) to determine the effects of mislocalized cytoplasmic TDP-43 on neuronal viability. Expression of either hTDP-43-ΔNLS or hTDP-43-WT led to neuron loss in selectively vulnerable forebrain regions, corticospinal tract degeneration, and motor spasticity recapitulating key aspects of FTLD and primary lateral sclerosis. Only rare cytoplasmic phosphorylated and ubiquitinated TDP-43 inclusions were seen in hTDP-43-ΔNLS mice, suggesting that cytoplasmic inclusions were not required to induce neuronal death. Instead, neurodegeneration in hTDP-43 and hTDP-43-ΔNLS-expressing neurons was accompanied by a dramatic downregulation of the endogenous mouse TDP-43. Moreover, mice expressing hTDP-43-ΔNLS exhibited profound changes in gene expression in cortical neurons. Our data suggest that perturbation of endogenous nuclear TDP-43 results in loss of normal TDP-43 function(s) and gene regulatory pathways, culminating in degeneration of selectively vulnerable affected neurons.

Citing Articles

Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence.

Mitra J, Kodavati M, Dharmalingam P, Guerrero E, Rao K, Garruto R Acta Neuropathol Commun. 2025; 13(1):54.

PMID: 40057796 PMC: 11889789. DOI: 10.1186/s40478-025-01962-9.


Decoding TDP-43: the molecular chameleon of neurodegenerative diseases.

Zeng J, Luo C, Jiang Y, Hu T, Lin B, Xie Y Acta Neuropathol Commun. 2024; 12(1):205.

PMID: 39736783 PMC: 11687198. DOI: 10.1186/s40478-024-01914-9.


A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in an AAV-C9ORF72 (GC) mouse model.

Thompson E, Spead O, Akerman S, Curcio C, Zaepfel B, Kent E Acta Neuropathol Commun. 2024; 12(1):203.

PMID: 39722074 PMC: 11670477. DOI: 10.1186/s40478-024-01911-y.


A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in a AAV- C9ORF72 (G 4 C 2) 66 mouse model.

Thompson E, Spead O, Akerman S, Curcio C, Zaepfel B, Kent E Res Sq. 2024; .

PMID: 39711523 PMC: 11661372. DOI: 10.21203/rs.3.rs-5221595/v1.


CK1δ/ε-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis.

Ko V, Ong K, Kwon D, Li X, Pietrasiewicz A, Harvey J Acta Neuropathol Commun. 2024; 12(1):187.

PMID: 39633494 PMC: 11619411. DOI: 10.1186/s40478-024-01902-z.


References
1.
Ayala Y, Misteli T, Baralle F . TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci U S A. 2008; 105(10):3785-9. PMC: 2268791. DOI: 10.1073/pnas.0800546105. View

2.
Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I . TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2010; 107(8):3858-63. PMC: 2840518. DOI: 10.1073/pnas.0912417107. View

3.
Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I . Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006; 441(7095):880-4. DOI: 10.1038/nature04723. View

4.
Carter R, Lione L, Humby T, Mangiarini L, Mahal A, Bates G . Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci. 1999; 19(8):3248-57. PMC: 6782264. View

5.
Guillemin I, Becker M, Ociepka K, Friauf E, Nothwang H . A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue. Proteomics. 2004; 5(1):35-45. DOI: 10.1002/pmic.200400892. View